Evaluation of effectiveness of quality-assured mammography screening in Germany: Sample size considerations and design options

European Journal of Cancer Prevention

Volumn 16, Issue 3, 2007, Pages 225-231

  Becker, Nikolaus ^a   Hakama, Matti ^b   Nyström, Lennarth ^c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF TAMPERE   (Finland)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Cancer registration; Data protection; Epidemiology; Mortality; Survival analysis

Indexed keywords

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CANCER SCREENING; CLINICAL EFFECTIVENESS; FOLLOW UP; GEOGRAPHIC PATHOLOGY; GERMANY; GROUPS BY AGE; HEALTH PROGRAM; HUMAN; MAMMOGRAPHY; MEDICAL CARE; PRIORITY JOURNAL; QUALITY CONTROL; SAMPLE SIZE;

AGED; BREAST NEOPLASMS; FEMALE; GERMANY; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; RESEARCH DESIGN; SAMPLE SIZE; SURVIVAL RATE;

EID: 34247092941     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000243857.91642.2d     Document Type: Article

References (25)

1. Becker N, Wahrendorf J (1997). Atlas of cancer mortality in the federal republic of Germany (1981-1990), 3rd ed. Berlin, Heidelberg, New York: Springer.
2. Becker N, Altenburg H-P, Stegmeier C, Ziegler H (2006). Report on recent evolution of incidence (1970-2002) of and mortality (1952-2002) from cancer in Germany. J Cancer Res Clin Oncol (in press).
3. Brenner H, Stegmaier C, Ziegler H (2005). Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium. Ann Oncol 16:981-986.
4. Breslow NE, Day NE (1987). Statistical methods in cancer research, Vol II. The design and analysis of cohort studies. Lyon, France: IARC Scientific Publications No 82 IARC.
5. Frischbier HJ, Hoeffken W, Robra BP (1994). Mammography in early detection of cancer [in German]. Stuttgart: Enke.
6. Hakama M, Pukkala E, Heikkilä M, Kallio M (1997). Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ 314:864-872.
7. Hakama M, Pukkala E, Soderman B, Day N (1999). Implementation of screening as a public health policy: issues in design and evaluation. J Med Screen 6:209-216.
8. IARC (2002). Breast cancer screening. IARC handbooks of cancer prevention. Vol 7. International agency for research on cancer. Lyon: World Health Organization. IARC Press.
9. Jonsson H, Nyström L, Törnberg S, Lenner P (2001). Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen 8:152-160.
10. Junkermann H, Becker N, Peitgen H-O (2001). German pilot projects of mammography screening [in German]. Radiologe 41:328-336.
11. Kassenärztliche Bundesvereinigung (2004). Introduction of a countrywide mammography screening programme [in German]. Deutsches Ärzteblatt 101:Supplement.
12. Katalinic (2004). Population-based cancer registration in Germany. Essentials and perspectives [in German]. Bundesgesundheitsblatt 47:422-428.
13. Köhler A, Gibis B, Mühlich A (2003). Mammographie-screening. Flächendeckendes Angebot bereits im Jahr 2005 [in German]. Deutsches Ärzteblatt 100:A1240-A1243.
14. Lenner P, Jonsson H (1997). Excess mortality from breast cancer in relation to mammography screening in northern Sweden. J Med Screen 4:6-9.
15. Levi F, Bosetti C, Lucchini F, Negri E, La Vecchia C (2005). Monitoring the decrease in breast cancer mortality in Europe. Eur J Cancer Prev 14:497-502.
16. Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydén S, et al. (1993). Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341:973-978.
17. Nyström L, Larsson L-G, Rutqvist LE, Lindgren A, Lindqvist M, Rydén S, et al. (1995). Determination of cause of death among breast cancer cases in the Swedish randomised mammography trials. Acta Oncologica 34:145-152.
18. Olsen AH, Njor SH, Vejborg I, SchwartzW, Dalgaard P, Jensen M-B, et al. (2005). Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 330:220-224.
19. Otto SJ, Fracheboud J, Looman CWN, Broeders MJM, Boer R, Hendriks JHCL, et al. The National Evaluation Team for Breast Cancer Screening (2003). Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 361:1411-1417.
20. Paci E, Giorgi D, Bianchi S, Vezzosi V, Zappa M, Crocetti E, Rosselli del Turco M (2002). Assessment of the early impact of the population-based breast cancer screening programme in Florence (Italy) using mortality and surrogate measures. Eur J Cancer 38:568-573.
21. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002.) Cancer incidence in five continents. Vol VIII. IARC Scientific Publications No. 155. Lyon: International Agency for Research on Cancer.
22. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, Puthaar E, editors. (2006). European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg: Office for Official Publications of the European Communities.
23. Prorok PC (1995). Screening studies. In: Greenwald P, Kramer BS, Weed DL, editors. Cancer prevention and control. New York, Basel, Hong Kong: Marcel Dekker; 225-242.
24. Schubert-Fritschle G, Eckel R, Eisenmenger W, Hölzel D (2002). Quality of information on death certificates [in German]. Deutsches Ärzteblatt 99:A50-A55.
25. Tabar L, Yen M-F, Vitak B, Tony Chen H-H, Smith RA, Duffy SW (2003). Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 361:405-1410.